nebulized adipose tissue-derived mesenchymal stem cell therapy（Kerman University of Medical Sciences）

N/A

Report date: 2023/01/12 15:41:04

Base Information

Drug Namenebulized adipose tissue-derived mesenchymal stem cell therapy（Kerman University of Medical Sciences）
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKerman University Of Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesKerman University Of Medical Sciences
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A